View in EDS HTML Full Text PDF Full Text

Inactivation of PRMT5 by PARP Inhibitors Confers High Susceptibility in MTAP-Deficient Cancers.

Saved in:
Bibliographic Details
Title: Inactivation of PRMT5 by PARP Inhibitors Confers High Susceptibility in MTAP-Deficient Cancers.
Authors: Liu, Qi1 (AUTHOR), Sheng, Yuling1,2 (AUTHOR), Lin, Folan2,3 (AUTHOR), Tan, Haoyuan1,4 (AUTHOR), Chang, Yanyun3,5 (AUTHOR), Lu, Xiaopeng1,4 (AUTHOR), Chen, Hao2,5 (AUTHOR) chenh7@sustech.edu.cn, Du, Changzheng3 (AUTHOR) dzza04606@btch.edu.cn
Source: Cancers. May2026, Vol. 18 Issue 9, p1335. 15p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:20726694
DOI:10.3390/cancers18091335